Page last updated: 2024-12-07

bornyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID6950274
CHEBI ID3151
MeSH IDM0194242

Synonyms (29)

Synonym
76-49-3
20347-65-3
bornyl acetate
5655-61-8
unii-mn65cc8l89
bornyl acetate, (+)-
(1r,2s,4r)-bornyl acetate
mn65cc8l89 ,
einecs 243-750-6
AKOS016012020
(+)-bornyl acetate
bicyclo(2.2.1)heptan-2-ol, 1,7,7-trimethyl-, 2-acetate, (1r,2s,4r)-
2-bornanol, acetate, (1r,2s,4r)-(+)-
(+)-bornyl, acetate
bornyl acetate d-form [mi]
bornyl acetate d-form
(1r,2s,4r)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate
CHEBI:3151
AC-34967
mfcd00867808
l-(-)-bornyl acetate
(+)-bornyl acetate, analytical standard
(+)-bornyl ace-tate
A879699
CS-0013974
HY-B1918
bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, 2-acetate, (1r,2s,4r)-
Q27284125
E88571
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Household Essentials1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Method Fragrance Boosters - Beach Sage -- 14.8 ozMethodHousehold Essentialsd-limonene, benzyl acetate, bornyl acetate, citral, citronellol, hexyl cinnamic aldehyde2024-11-29 10:47:42

Drug Classes (2)

ClassDescription
monoterpenoidAny terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (9.76)18.2507
2000's11 (26.83)29.6817
2010's22 (53.66)24.3611
2020's4 (9.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.44%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (95.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]